As of October 17, 2026, Cytokinetics Inc (CYTK) is trading at $61.95. BlackOwl's AI analysis indicates a bullish outlook with 65% confidence and a price target of $71.00 (14.6% above the current price).

C

CYTK

$61.95 bullish

Cytokinetics Inc

Trade
No chart data available for this period

Over a 2-week timeframe, CYTK is positioned for a bullish recovery toward the $71.00 level. Upcoming presentations at the HFSA Annual Scientific Meeting and plans for supplemental NDA filing provide strong fundamental catalysts to offset current technical consolidation.

Trend

bullish

Confidence

65%

Price Target

$71.00

+14.6% from current

Timeframe

2 Weeks

Until 10/16/2026

Key Insights

  • Anticipation of presentations at the HFSA meeting can drive medium-term upward momentum
  • Price is hovering near the 50-day SMA ($65.52), setting a foundation for recovery

Risk Factors

  • Continued cash burn common in late-stage biopharmaceutical firms
  • Broader healthcare sector headwinds could delay recovery

Actionable Items

  • Accumulate shares on weakness toward the 50-day moving average
  • Track news flow from upcoming medical presentations

News Sentiment

News Count

1

Impact Level

high

Sentiment

Positive

Key Topics

aficamtenregulatory milestonelabel expansion

Key Statistics

P/E Ratio —
Forward P/E —
EPS (TTM) —
Beta —
Div. Yield —
ROE —
ROA -56.76%
ROI -85.25%
52W High —
52W Low —
Dividend —
Market Cap —

New to reading these? Start with how to research stocks.

Related Tickers

L
LLY

Lilly(Eli) & Co

$1,257.03
+0.4%
J
JNJ

Johnson & Johnson

$255.56
+0.9%
A
ABBV

Abbvie Inc

$285.42
+0.7%
U
UNH

Unitedhealth Group Inc

$401.43
-1.3%
M
MRK

Merck & Co Inc

$145.95
+0.5%

Frequently Asked Questions

What is Cytokinetics Inc's current stock price?
As of October 17, 2026, Cytokinetics Inc (CYTK) is trading at $61.95 per share. This is AI-generated analysis for informational purposes only, not financial advice.
What does BlackOwl's AI model project for CYTK?
BlackOwl's model reads CYTK as bullish in the medium term with 65% confidence, with a price target of $71.00 — 14.6% above the current price of $61.95. This is AI-generated analysis for informational purposes only, not financial advice.
What is CYTK's P/E ratio?
P/E ratio data is not currently available for CYTK. This is AI-generated analysis for informational purposes only, not financial advice.
How do I buy CYTK stock?
You can buy Cytokinetics Inc (CYTK) directly through BlackOwl with one click. Sign up for a free account, connect your brokerage, and trade instantly. This is AI-generated analysis for informational purposes only, not financial advice.

Get AI-powered insights for CYTK

Unlock real-time signals, personalized risk analysis, and trade recommendations.

Try BlackOwl Free